Free Trial

Eloxx Pharmaceuticals (ELOX) SEC Filings & 10K Form

Eloxx Pharmaceuticals logo

Recent Eloxx Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/20/2024
7:13 PM
Advent Life Sciences LLP (Filed by)
Eloxx Pharmaceuticals, Inc. (Subject)
Eloxx Pharmaceuticals (Subject)
Form SC 13D/A
07/16/2024
4:23 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:11 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
1:20 PM
Eloxx Pharmaceuticals, Inc. (Subject)
Eloxx Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
03/14/2024
3:30 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:44 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/09/2024
4:10 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:11 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ELOX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners